NEW YORK--(BUSINESS WIRE)--March 22, 2006--ZIOPHARM Oncology, Inc. (OTC BB: ZIOP), a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs, announced 2005 financial results and the filing of its Annual Report on Form 10-KSB.
